Amphastar Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	223.61	170.18	151.61	144.3	156.1	126.35
Short-Term Investments	66.51	112.64	70.04	112.51	19.66	10.32
Cash & Short-Term Investments	290.12	282.81	221.65	256.81	175.76	136.67
Cash Growth	25.19%	27.60%	-13.69%	46.11%	28.60%	29.40%
Accounts Receivable	144.86	143.56	136.29	114.94	88.8	78.8
Other Receivables	2.63	17.17	1.75	0.53	0.17	0.13
Receivables	147.49	160.73	138.04	115.47	88.98	78.93
Inventory	179.91	176.89	153.74	105.83	103.58	92.81
Prepaid Expenses	11	13.15	18.21	9.06	7.56	7.27
Restricted Cash	0.24	0.24	0.24	0.24	0.24	0.24
Other Current Assets	2.2	2.2	2.2	2.2	2.2	2.2
Total Current Assets	630.95	636.02	534.07	489.6	378.32	318.12
Property, Plant & Equipment	389.13	353.72	344.63	315.64	264.57	271.49
Long-Term Investments	-	-	11	15.21	2.41	3.99
Goodwill	3.31	3.4	3.05	3.22	3.13	3.31
Other Intangible Assets	644.52	562.56	587.61	610.08	34.17	35.56
Long-Term Deferred Tax Assets	42.46	42.46	71.12	53.25	38.53	22.4
Other Long-Term Assets	33.39	31.14	25.99	25.91	20.86	16.67
Total Assets	1,744	1,629	1,577	1,513	741.99	671.53
Accounts Payable	28.93	32.59	30.51	25.44	20.5	22.21
Accrued Expenses	201.7	96.76	103.1	54.75	46.19	44.17
Current Portion of Long-Term Debt	2.49	1.47	0.23	0.44	3.05	2.2
Current Portion of Leases	8.8	8.1	6.8	3.91	3	2.98
Current Income Taxes Payable	0.55	0.24	9.66	1.61	4.57	9.08
Other Current Liabilities	20.74	19	23.44	139.27	17.55	23.16
Total Current Liabilities	263.21	158.16	173.76	225.41	94.86	103.81
Long-Term Debt	609.38	608.66	601.2	588.96	72.84	74.38
Long-Term Leases	67.66	37.77	42.31	30.34	23.69	25.1
Pension & Post-Retirement Benefits	2.6	2.6	2.6	2.6	-	-
Long-Term Deferred Tax Liabilities	-	-	-	-	0.14	0.53
Other Long-Term Liabilities	32.77	33.31	25.3	26.18	21.79	22.18
Total Liabilities	975.61	840.49	845.17	873.49	213.33	226.01
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	553	535.38	505.4	486.06	455.08	422.42
Retained Earnings	703.65	666.88	568.79	409.27	271.72	180.34
Treasury Stock	-482.6	-408.15	-332.71	-247.43	-189.52	-150.48
Comprehensive Income & Other	-5.9	-5.31	-9.18	-8.48	-8.62	-6.77
Total Common Equity	768.16	788.81	732.3	639.42	528.66	445.52
Shareholders' Equity	768.16	788.81	732.3	639.42	528.66	445.52
Total Liabilities & Equity	1,744	1,629	1,577	1,513	741.99	671.53
Total Debt	688.32	656	650.55	623.64	102.58	104.66
Net Cash (Debt)	-398.2	-373.19	-428.9	-366.84	73.18	32.01
Net Cash Growth	-	-	-	-	128.62%	-16.53%
Net Cash Per Share	-8.59	-7.74	-8.24	-6.92	1.40	0.64
Filing Date Shares Outstanding	42.54	45.37	47.65	48.1	47.9	48.15
Total Common Shares Outstanding	42.53	45.65	47.62	48.07	48.11	47.71
Working Capital	367.75	477.86	360.31	264.19	283.46	214.31
Book Value Per Share	18.06	17.28	15.38	13.30	10.99	9.34
Tangible Book Value	120.32	222.84	141.64	26.13	491.36	406.65
Tangible Book Value Per Share	2.83	4.88	2.97	0.54	10.21	8.52
Land	7.52	7.55	7.42	7.48	7.45	7.62
Buildings	196.36	196.68	169.43	168.77	130.73	130.58
Machinery	352.26	342.1	313.38	291.43	237.74	235.26
Construction In Progress	34.77	24.41	36.69	18.68	50.84	41.19
Leasehold Improvements	46.37	46.1	42.01	41.69	31.54	29.22

SEC Filings: 10-K · 10-Q